table of content
1 Study Coverage
1.1 Injectable Drug Delivery Formulation Product Introduction
1.2 Global Injectable Drug Delivery Formulation Outlook 2017 VS 2022 VS 2028
1.2.1 Global Injectable Drug Delivery Formulation Sales in US$ Million for the Year 2017-2028
1.2.2 Global Injectable Drug Delivery Formulation Sales in Volume for the Year 2017-2028
1.3 United States Injectable Drug Delivery Formulation Outlook 2017 VS 2022 VS 2028
1.3.1 United States Injectable Drug Delivery Formulation Sales in US$ Million for the Year 2017-2028
1.3.2 United States Injectable Drug Delivery Formulation Sales in Volume for the Year 2017-2028
1.4 Injectable Drug Delivery Formulation Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Injectable Drug Delivery Formulation in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Injectable Drug Delivery Formulation Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Injectable Drug Delivery Formulation Market Dynamics
1.5.1 Injectable Drug Delivery Formulation Industry Trends
1.5.2 Injectable Drug Delivery Formulation Market Drivers
1.5.3 Injectable Drug Delivery Formulation Market Challenges
1.5.4 Injectable Drug Delivery Formulation Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Injectable Drug Delivery Formulation Market Segment by Type
2.1.1 Conventional Drug Delivery Formulations
2.1.2 Novel Drug Delivery Formulations
2.1.3 Long-acting Formulations
2.2 Global Injectable Drug Delivery Formulation Market Size by Type
2.2.1 Global Injectable Drug Delivery Formulation Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Injectable Drug Delivery Formulation Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Injectable Drug Delivery Formulation Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Injectable Drug Delivery Formulation Market Size by Type
2.3.1 United States Injectable Drug Delivery Formulation Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Injectable Drug Delivery Formulation Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Injectable Drug Delivery Formulation Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Injectable Drug Delivery Formulation Market Segment by Application
3.1.1 Autoimmune Diseases
3.1.2 Hormonal Disorders
3.1.3 Oncology
3.1.4 Orphan Diseases
3.1.5 Others
3.2 Global Injectable Drug Delivery Formulation Market Size by Application
3.2.1 Global Injectable Drug Delivery Formulation Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Injectable Drug Delivery Formulation Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Injectable Drug Delivery Formulation Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Injectable Drug Delivery Formulation Market Size by Application
3.3.1 United States Injectable Drug Delivery Formulation Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Injectable Drug Delivery Formulation Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Injectable Drug Delivery Formulation Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Injectable Drug Delivery Formulation Competitor Landscape by Company
4.1 Global Injectable Drug Delivery Formulation Market Size by Company
4.1.1 Top Global Injectable Drug Delivery Formulation Manufacturers Ranked by Revenue (2021)
4.1.2 Global Injectable Drug Delivery Formulation Revenue by Manufacturer (2017-2022)
4.1.3 Global Injectable Drug Delivery Formulation Sales by Manufacturer (2017-2022)
4.1.4 Global Injectable Drug Delivery Formulation Price by Manufacturer (2017-2022)
4.2 Global Injectable Drug Delivery Formulation Concentration Ratio (CR)
4.2.1 Injectable Drug Delivery Formulation Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Injectable Drug Delivery Formulation in 2021
4.2.3 Global Injectable Drug Delivery Formulation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Injectable Drug Delivery Formulation Manufacturing Base Distribution, Product Type
4.3.1 Global Injectable Drug Delivery Formulation Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Injectable Drug Delivery Formulation Product Type
4.3.3 Date of International Manufacturers Enter into Injectable Drug Delivery Formulation Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Injectable Drug Delivery Formulation Market Size by Company
4.5.1 Top Injectable Drug Delivery Formulation Players in United States, Ranked by Revenue (2021)
4.5.2 United States Injectable Drug Delivery Formulation Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Injectable Drug Delivery Formulation Sales by Players (2020, 2021 & 2022)
5 Global Injectable Drug Delivery Formulation Market Size by Region
5.1 Global Injectable Drug Delivery Formulation Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Injectable Drug Delivery Formulation Market Size in Volume by Region (2017-2028)
5.2.1 Global Injectable Drug Delivery Formulation Sales in Volume by Region: 2017-2022
5.2.2 Global Injectable Drug Delivery Formulation Sales in Volume Forecast by Region (2023-2028)
5.3 Global Injectable Drug Delivery Formulation Market Size in Value by Region (2017-2028)
5.3.1 Global Injectable Drug Delivery Formulation Sales in Value by Region: 2017-2022
5.3.2 Global Injectable Drug Delivery Formulation Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Injectable Drug Delivery Formulation Market Size YoY Growth 2017-2028
6.1.2 North America Injectable Drug Delivery Formulation Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Injectable Drug Delivery Formulation Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Injectable Drug Delivery Formulation Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Injectable Drug Delivery Formulation Market Size YoY Growth 2017-2028
6.3.2 Europe Injectable Drug Delivery Formulation Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Injectable Drug Delivery Formulation Market Size YoY Growth 2017-2028
6.4.2 Latin America Injectable Drug Delivery Formulation Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Injectable Drug Delivery Formulation Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Injectable Drug Delivery Formulation Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Becton, Dickinson and Company (US)
7.1.1 Becton, Dickinson and Company (US) Corporation Information
7.1.2 Becton, Dickinson and Company (US) Description and Business Overview
7.1.3 Becton, Dickinson and Company (US) Injectable Drug Delivery Formulation Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Becton, Dickinson and Company (US) Injectable Drug Delivery Formulation Products Offered
7.1.5 Becton, Dickinson and Company (US) Recent Development
7.2 Baxter International Inc. (US)
7.2.1 Baxter International Inc. (US) Corporation Information
7.2.2 Baxter International Inc. (US) Description and Business Overview
7.2.3 Baxter International Inc. (US) Injectable Drug Delivery Formulation Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Baxter International Inc. (US) Injectable Drug Delivery Formulation Products Offered
7.2.5 Baxter International Inc. (US) Recent Development
7.3 Gerresheimer AG (Germany)
7.3.1 Gerresheimer AG (Germany) Corporation Information
7.3.2 Gerresheimer AG (Germany) Description and Business Overview
7.3.3 Gerresheimer AG (Germany) Injectable Drug Delivery Formulation Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Gerresheimer AG (Germany) Injectable Drug Delivery Formulation Products Offered
7.3.5 Gerresheimer AG (Germany) Recent Development
7.4 Pfizer, Inc. (US)
7.4.1 Pfizer, Inc. (US) Corporation Information
7.4.2 Pfizer, Inc. (US) Description and Business Overview
7.4.3 Pfizer, Inc. (US) Injectable Drug Delivery Formulation Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Pfizer, Inc. (US) Injectable Drug Delivery Formulation Products Offered
7.4.5 Pfizer, Inc. (US) Recent Development
7.5 Schott AG (Germany)
7.5.1 Schott AG (Germany) Corporation Information
7.5.2 Schott AG (Germany) Description and Business Overview
7.5.3 Schott AG (Germany) Injectable Drug Delivery Formulation Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Schott AG (Germany) Injectable Drug Delivery Formulation Products Offered
7.5.5 Schott AG (Germany) Recent Development
7.6 Sandoz (Germany)
7.6.1 Sandoz (Germany) Corporation Information
7.6.2 Sandoz (Germany) Description and Business Overview
7.6.3 Sandoz (Germany) Injectable Drug Delivery Formulation Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Sandoz (Germany) Injectable Drug Delivery Formulation Products Offered
7.6.5 Sandoz (Germany) Recent Development
7.7 Teva Pharmaceutical Industries Ltd. (Israel)
7.7.1 Teva Pharmaceutical Industries Ltd. (Israel) Corporation Information
7.7.2 Teva Pharmaceutical Industries Ltd. (Israel) Description and Business Overview
7.7.3 Teva Pharmaceutical Industries Ltd. (Israel) Injectable Drug Delivery Formulation Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Teva Pharmaceutical Industries Ltd. (Israel) Injectable Drug Delivery Formulation Products Offered
7.7.5 Teva Pharmaceutical Industries Ltd. (Israel) Recent Development
7.8 Eli Lilly and Company (US)
7.8.1 Eli Lilly and Company (US) Corporation Information
7.8.2 Eli Lilly and Company (US) Description and Business Overview
7.8.3 Eli Lilly and Company (US) Injectable Drug Delivery Formulation Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Eli Lilly and Company (US) Injectable Drug Delivery Formulation Products Offered
7.8.5 Eli Lilly and Company (US) Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Injectable Drug Delivery Formulation Industry Chain Analysis
8.2 Injectable Drug Delivery Formulation Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Injectable Drug Delivery Formulation Distributors
8.3 Injectable Drug Delivery Formulation Production Mode & Process
8.4 Injectable Drug Delivery Formulation Sales and Marketing
8.4.1 Injectable Drug Delivery Formulation Sales Channels
8.4.2 Injectable Drug Delivery Formulation Distributors
8.5 Injectable Drug Delivery Formulation Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
